L. Frederick

Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist

R. Anders, A. Salyers, J. A. Szalony, 2001, Medicinal research reviews.

Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.

L. Feigen, A. Salyers, J. A. Szalony, 1998, Circulation.

Symptoms and blood glucose levels in diabetics.

D. Cox, W. Clarke, S. Pohl, 1985, JAMA.

The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosis.

L. Feigen, A. Salyers, O. D. Suleymanov, 1996, Circulation.

Effect of SC‐40230, a new class I antiarrhythmic agent, on canine ventricular tachycardias

S. Garthwaite, C. Cook, L. Frederick, 1989 .

Canine plasma concentration‐cardiovascular effect relationships for bidisomide, a new antiarrhythmic drug, and disopyramide, cibenzoline, and propafenone

S. Garthwaite, C. Cook, L. Frederick, 1995 .